NathansonLab

Working on a cure for brain cancer — Official lab twitter of the Nathanson Lab at UCLA #gbm #GliomaPDOX #xenografts #braincancer #drugdevelopment

[NathansonLab @NathansonLab]

Check out our latest paper integrating genomic and functional precision medicine to identify therapeutic vulnerabilities in glioblastoma

https://t.co/Xka3S4XdB2

[National Brain Tumor Society @NBTStweets]

Today, on #InternationalWomensDay, we’re celebrating NBTS-funded researcher Dr. Elizabeth Fernandez, who just defended her PhD!

Inspired by her cousin’s #braintumor, she’s working to overcome #glioblastoma treatment resistance and advance #precisionmedicine. #WomenInScience

[NathansonLab @NathansonLab]

@graeber_thomas @SJD956 @jsb_ucla @NBTStweets @UncleKoryFndn @NatureComms

[NathansonLab @NathansonLab]

Check out our latest paper integrating genomic and functional precision medicine to identify therapeutic vulnerabilities in glioblastoma

https://t.co/Xka3S4XdB2

[NathansonLab @NathansonLab]

This work was a collaborative effort with @graeber_thomas @SJD956 @jsb_ucla and other colleagues

We are honored for the support and partnership from Pennymac and the Kurland Family Foundation, @NBTStweets @UncleKoryFndn and others

[NathansonLab @NathansonLab]

We are so honored to be partnering with Pennymac and the Kurland Family Foundation in the fight against brain cancer. Thank you to all the donors and supporters of this cause.

[UCLA Neurology @UCLANeurology]

Thank you to all of the sponsors and donors at the 3rd Annual Stanford L. Kurland Memorial Golf Classic to benefit brain cancer research at UCLA Neurology. Pennymac raised over $2.3 million in the fight to end brain cancer, as they carry on the legacy of founder, Stan Kurland.

[NathansonLab @NathansonLab]

Excited for this new year! Looking forward to all the fun science we'll do together.

[NathansonLab @NathansonLab]

Congratulations Jennifer Salinas, graduate student at
@NathansonLab for advancing to candidacy. We cannot wait to see all the wonderful things you do for your PhD! #Glioblastoma #metabolism

[NathansonLab @NathansonLab]

A lovely @NathansonLab dinner in the middle of all the cool science at #SNO2023

[NathansonLab @NathansonLab]

Exciting work on trans-differentiation in cancer published in @Cancer_Cell from our colleagues and friends in the @graeber_thomas Lab and Witte Lab at UCLA.
https://t.co/RRAZwMBpk6

[PhiOanh "Leia" NghiemPhu, MD @Leia_N_MD]

UCLA Brain Tumor Center teams, @UCLANeurology #NeuroOnc @UCLANsgy @NathansonLab, UCLA Brain Tumor Imaging Lab at #sno2023

[NathansonLab @NathansonLab]

Congratulations Jenna for receiving the Basic Science Award at #SNO2023 for her talk titled 'CDKN2A Deletion Remodels Lipid Metabolism to Prime #Glioblastoma for Ferroptosis'. We are proud of your achievements!

[NathansonLab @NathansonLab]

Did you check out Elizabeth's wonderful poster about the apoptotic machinery in #glioblastoma #GBM at SNO this weekend?
#SNO2023

[. @UCLAJCCC]

Congrats to @NathansonLab, @ben_ellingson & Dr. Timothy Cloughesy, who received $2.5M from the @DeptofDefense to develop a tailored treatment for patients with glioblastoma, a deadly brain tumor with limited treatment options.

https://t.co/gc20RLczMG

[NathansonLab @NathansonLab]

Congratulations to our PhD candidate @Marissa_Pioso for receiving the prestigious @theNCI T32 fellowship in Tumor Cell Biology @UCLA to investigate how oncogenic signaling impairs immune response in GBM!

[NathansonLab @NathansonLab]

In case you missed it, check out our latest paper featured on the cover of the June issue of @Cancer_Cell! 🐻🦊

[Cancer Cell @Cancer_Cell]

A new issue of Cancer Cell is available now! Check our exciting content for June: https://t.co/8XiwzFPweH

[NathansonLab @NathansonLab]

Check out this study co-led by our collaborator, Dr. Timothy Cloughesy, which is the first clinical trial to employ a targeted therapy specifically developed to treat brain tumors.

[NEJM @NEJM]

Original Article: Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma (INDIGO) https://t.co/qypyIPmLsy

#ASCO23

[NathansonLab @NathansonLab]

Read more about this work here: https://t.co/MhmQBUPJIe
@UCLAJCCC

[NathansonLab @NathansonLab]

#GBM are lethal, molecularly heterogeneous tumors – it was unknown whether this molecular diversity led to distinct phenotypes and metabolic lipidomic vulnerabilities. New, open access @Cancer_Cell paper: https://t.co/oDke8Daqda

[NathansonLab @NathansonLab]

In collaboration with @SJD956, Steve Bensinger, @TCloughesy, Kevin Williams, @graeber_thomas, and Linda Liau we created a lipidomic and molecular resource of GBM tumors and identified that CDKN2A deletion remodels the GBM lipidome, priming these GBM for ferroptosis.